Clinical trial
Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate…
NCT00005827 · UNC Lineberger Comprehensive Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00005827 |
|---|---|
| Title | Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer |
| Official title | Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical Study of Genistein in Normal Volunteers and in Prostate Neoplasia (Multiple Dose Safety and Pharmacokinetic Clinical Study of Genistein in Prostate Neoplasia) |
| Lead sponsor | UNC Lineberger Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement |
| Interventions | genistein |
| Enrollment | 0 |
| Start date | Dec 1, 1999 |
| Primary completion | May 1, 2003 |
| Completion | May 1, 2003 |
| First posted | Apr 20, 2004 |
| Last update posted | Apr 24, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: